Prediction of Clinical Response to Drugs in Ovarian Cancer Using the Chemotherapy Resistance Test (CTR-test)

Journal of Ovarian Research - United Kingdom
doi 10.1186/s13048-017-0365-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

A Study on the Sensitivity Test of Cancer Cells to Anticancer Drugs

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1966English

Prediction of Pathological Response to Primary Systemic Chemotherapy for Breast Cancer

Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
2011English

The Combined Dexamethasone/CRH Test (DEX/CRH Test) and Prediction of Acute Treatment Response in Major Depression

PLoS ONE
Multidisciplinary
2009English

Pre-Test Prediction Models of BRCA1 or BRCA2 Mutation in Breast/Ovarian Families Attending Familial Cancer Clinics

Journal of Medical Genetics
Genetics
2003English

Enhancing Chemotherapy Response With Bmi-1 Silencing in Ovarian Cancer

PLoS ONE
Multidisciplinary
2011English

PARP Inhibitors in Ovarian Cancer: Sensitivity Prediction and Resistance Mechanisms

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Global Gene Expression Analysis of Early Response to Chemotherapy Treatment in Ovarian Cancer Spheroids

BMC Genomics
BiotechnologyGenetics
2008English

Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy

Hereditary Cancer in Clinical Practice
OncologyGenetics
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy